Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) FCF Margin: 2010-2024

Historic FCF Margin for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -11.89%.

  • China Pharma Holdings' FCF Margin fell 2799.00% to -31.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.03%, marking a year-over-year increase of 1606.00%. This contributed to the annual value of -11.89% for FY2024, which is 174.00% down from last year.
  • As of FY2024, China Pharma Holdings' FCF Margin stood at -11.89%, which was down 17.20% from -10.14% recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' FCF Margin ranged from a high of -7.13% in FY2021 and a low of -11.89% during FY2024.
  • Moreover, its 3-year median value for FCF Margin was -10.14% (2023), whereas its average is -10.68%.
  • As far as peak fluctuations go, China Pharma Holdings' FCF Margin slumped by 1,269bps in 2020, and later spiked by 124bps in 2021.
  • China Pharma Holdings' FCF Margin (Yearly) stood at -8.37% in 2020, then surged by 124bps to -7.13% in 2021, then crashed by 288bps to -10.01% in 2022, then fell by 13bps to -10.14% in 2023, then slumped by 174bps to -11.89% in 2024.